REFERENCES
1. Borrajo GJC. Newborn screening in Latin America: a brief overview of the state of the art. Am J Med Genet C Semin Med Genet 2021;187:322-8.
2. Giugliani R, Castillo Taucher S, Hafez S, et al. Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America. Front Genet 2022;13:1053559.
3. American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group. Tandem mass spectrometry in newborn screening. American college of medical genetics/American society of human genetics test and technology transfer committee working group. Genet Med 2000;2:267-9.
4. Vela-Amieva M, Belmont-Martínez L, Ibarra-González I, Fernández-Lainez C. Institutional variability of neonatal screening in Mexico. Bol Med Hosp Infant Mex 2009;66:431-9. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=21973 [Last accessed on 14 Jun 2024].
5. García-Flores EP, Herrera-Maldonado N, Hinojosa-Trejo MA, Vergara-Vázquez M, Halley-Castillo ME. Progress and achievements of the neonatal metabolic screening program (2012-2018). Pediatr Act Mex 2018;39:57.
6. Camino HC, Cantú-Reyna C. Incidencia de errores innatos del metabolismo, endocrinopatías, hemoglobinopatías y otros desórdenes detectados por tamiz metabólico ampliado. Rev Médica Petróleos Mex 2018;11:72-83. Available from: https://www.researchgate.net/publication/339565795_Incidencia_de_errores_innatos_del_metabolismo_endocrinopatias_hemoglobinopatias_y_otros_desordenes_detectados_por_tamiz_metabolico_ampliado [Last accessed on 20 Jun 2024].
7. Navarrete-Martínez JI, Limón-Rojas AE, Gaytán-García MJ, et al. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: three-year findings from a screening program in a closed Mexican health system. Mol Genet Metab 2017;121:16-21.
8. Trigo-Madrid M, Díaz-Gallardo J, Mar-Aldana R, et al. Results of the expanded neonatal screening program and perinatal epidemiology in the health services of the secretariat of the navy of Mexico. Pediatr Act Mex 2014;35:448-58. Available from: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-23912014000600003&lng=es&tlng= [Last accessed on 14 Jun 2024].
9. XVI legislature of the state of Quintana Roo, decree to reform article 56 of the state health law. Available from: http://documentos.congresoqroo.gob.mx/decretos/EXVI-2021-09-04-137.pdf [Last accessed on 14 Jun 2024].
10. LXV legislature of the state of Quintana Roo. Available from: https://congreso-gto.s3.amazonaws.com/uploads/orden_archivo/archivo/31179/14_Dictamen_refLSE_materinf-tamizmeapli_240-323B-413-LXV-I.pdf [Last accessed on 14 Jun 2024].
11. LXV legislature of the congress of the United Mexican States. Decree to reform article 157 bis of the general health law. Available from: https://www.diputados.gob.mx/LeyesBiblio/minutas/65/CS-LXV-I-1P-022/02_dictamen_a2_010_08mar23.pdf [Last accessed on 14 Jun 2024].
12. Lazcano-Ponce E, Schiavon R, Uribe-Zúñiga P, et al. Coverage for birth care in Mexico and its interpretation within the context of maternal mortality. Publ Health Mex 2013;55:S214-24.
13. Ibarra-González I, Fernández-Lainez C, Vela-Amieva M, et al. A review of disparities and unmet newborn screening needs over 33 years in a cohort of Mexican patients with inborn errors of intermediary metabolism. Int J Neonatal Screen 2023;9:59.
14. Chaytow H, Faller KME, Huang YT, Gillingwater TH. Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine. Cell Rep Med 2021;2:100346.
15. NeuroVoices: Crystal Proud, MD, on improving SMA outcomes through a combination approach. Available from: https://www.neurologylive.com/view/neurovoices-crystal-proud-improving-sma-outcomes-through-combination-approach [Last accessed on 20 Jun 2024].
16. Bodian DL, Klein E, Iyer RK, et al. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med 2016;18:221-30.
17. Ceyhan-Birsoy O, Murry JB, Machini K, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq project. Am J Hum Genet 2019;104:76-93.
18. Velásquez A, Vela-Amieva M, Waylor EW, Chace DH. Results of the sieve enlarged newborn, as new strategy for the prevention of the defects from birth. Rev Mex Pediatr 2000;67:206-13. Available from https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=2748 [Last accessed on 14 Jun 2024].
19. Downie L, Halliday J, Lewis S, Amor DJ. Principles of genomic newborn screening programs: a systematic review. JAMA Netw Open 2021;4:e2114336.
21. Minten T, Gold NB, Bick S, et al. Determining the characteristics of genetic disorders that predict inclusion in newborn genomic sequencing programs. medRxiv 2024.
22. Bros-facer V, Taylor S, Patch C. Next-generation sequencing-based newborn screening initiatives in Europe: an overview. Rare Dis Orphan Drugs J 2023;2:21.
23. Florentine MM, Rouse SL, Stephans J, et al. Racial and ethnic disparities in diagnostic efficacy of comprehensive genetic testing for sensorineural hearing loss. Hum Genet 2022;141:495-504.
24. Chen E, Facio FM, Aradhya KW, et al. Rates and classification of variants of uncertain significance in hereditary disease genetic testing. JAMA Netw Open 2023;6:e2339571.
25. Gonzaga-Jauregui C. Chapter 13: challenges and opportunities in rare diseases. In: Gonzaga-Jauregui C, Lupski JR, editors. Genomics of rare diseases: understanding disease genetics using genomic approaches. San Diego: Academic Press/Elsevier Inc., 2021, pp. 263-84.
26. Cabello JF, Novoa F, Huff HV, Colombo M. Expanded newborn screening and genomic sequencing in Latin America and the resulting social justice and ethical considerations. Int J Neonatal Screen 2021;7:6.
27. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med 2018;3:10.
28. Chung CCY, Leung GKC, Mak CCY, et al. Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs. Lancet Reg Health West Pac 2020;1:100001.
29. Dimmock D, Caylor S, Waldman B, et al. Project baby bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet 2021;108:1231-8.
